PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,371,402 | -23.0% | 10,224,120 | +22.6% | 0.43% | -25.7% |
| Q2 2023 | $110,896,996 | +50.7% | 8,338,120 | +31.2% | 0.58% | +41.5% |
| Q1 2023 | $73,592,290 | +124.7% | 6,355,120 | +58.7% | 0.41% | +108.7% |
| Q4 2022 | $32,755,992 | +120.6% | 4,004,400 | +145.4% | 0.20% | +170.8% |
| Q1 2022 | $14,849,000 | -64.5% | 1,631,800 | -20.2% | 0.07% | -65.6% |
| Q4 2021 | $41,851,000 | -17.8% | 2,045,488 | +2.7% | 0.21% | -12.2% |
| Q3 2021 | $50,902,000 | +482.2% | 1,992,250 | +696.9% | 0.24% | +561.1% |
| Q2 2021 | $8,743,000 | -84.0% | 250,000 | -88.1% | 0.04% | -89.0% |
| Q4 2020 | $54,474,000 | +35.8% | 2,100,000 | -48.3% | 0.33% | +18.4% |
| Q3 2020 | $40,109,000 | +287.5% | 4,063,770 | +35.5% | 0.28% | +233.7% |
| Q2 2020 | $10,350,000 | +12.7% | 3,000,000 | 0.0% | 0.08% | +5.1% |
| Q1 2020 | $9,180,000 | -40.5% | 3,000,000 | 0.0% | 0.08% | -24.0% |
| Q4 2019 | $15,420,000 | – | 3,000,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |